INFORMAZIONE E APPROFONDIMENTO
Questo articolo proviene da Medical Xpress – Melanoma.
Il contenuto è riportato a solo scopo informativo e divulgativo: la proprietà e la responsabilità restano dell’autore e della fonte originale, e le informazioni non sostituiscono in alcun modo il parere del medico. Ringraziamo Medical Xpress – Melanoma per il prezioso lavoro di informazione: puoi leggere l’articolo originale sul loro sito.
This article comes from Medical Xpress – Melanoma.
The content is shared for informational and educational purposes only: ownership and responsibility remain with the original author and source, and this information is no substitute for medical advice. We thank Medical Xpress – Melanoma for their valuable work: you can read the original article on their website.
Melanoma is one of the most difficult cancers to treat due to its resistance to targeted drug therapies. But a new study from the University of Kentucky Markey Cancer Center shows that the cancer is playing offense as well as
Pubblicato: 23/10/2026
Melanoma is one of the most difficult cancers to treat due to its resistance to targeted drug therapies. But a new study from the University of Kentucky Markey Cancer Center shows that the cancer is playing offense as well as defense: In addition to forming resistance against the MAPK inhibitors that are commonly used to treat it, the cancer also actively suppresses the immune cells that would otherwise help eliminate it.
Leggi l'articolo originale su Medical Xpress – Melanoma
PUBBLICITÀ
Questi contenuti non sostituiscono una visita medica. Se noti un cambiamento o hai dubbi, rivolgiti al medico.
PUBBLICITÀ